Lenacapavir: NDA approves HIV prevention shot
Uganda’s National Drug Authority (NDA) has approved lenacapavir, a twice-yearly injectable HIV prevention drug manufactured by U.S.-based Gilead Sciences. “This is a game-changer for HIV prevention, especially for those at high risk. This is a great step towards ending AIDS by 2030,” NDA said on X. The long-acting pre-exposure prophylaxis (PrEP) offers high-risk adults and…
